Oncology (Cancer)

Palcohol powdered alcohol approved and now not approved

 

young women drinking Palcohol. Powdered alcohol. Convenient for hikers, kayakers, anywhere where weight is an issue, but could the very convenience it brings increase risk of alcohol poisoning and under age drinking?

Members Only: 

 

young women drinking Palcohol. Powdered alcohol. Convenient for hikers, kayakers, anywhere where weight is an issue, but could the very convenience it brings increase risk of alcohol poisoning and under age drinking?

These appear to be the challenges that Lipsmark, the company that makes Palcohol and Mark Phillips, the company president are now facing.

In a recent interview, the president noted that he came up with the idea for use in hiking and wanting to enjoy an alcoholic beverage when the day is done. One of the Rum, Vodka, Cosmopolitan or Powderita packets apparently has as much alcohol as a typical drink. The prevalent video shows Mr. Phillips reconstituting a packet, then pouring a drink.

 

Concerns arose in the media and from legislators almost immediately. Colorado and several other states banned the product. Approval for the product apparently has been reversed.

This editor immediately had the caution reaction, noting that the recently released Essential Guide to Prescription Drugs, Update on Alcohol helps people understand how to drink safely and avoid interactions, but that the book didn't contain Palcohol data (except in the sense of a standard drink and being careful of intake).

 

The saga of Palcohol is not over, but is apprently being reviewed. There are several cases of prescription drugs where medguides (and perhaps the Essential Guide) could be used to teach people about the product and help avoid problems. Perhaps a limitation on sales (5 packets at a time to any single person) could help.

 

More to follow as always once new information becomes available.

Contrave and cardiology--could this newer weight loss drug help your heart too?

food

Members Only: 

food Contrave (bupropion and naltrexone) is apparently unique. The SEC disclosed that the US patent office gave the 371 patent to Orexigen Therapeutics based on an interim look at the LIGHT study. What this means is that Contrave has a claim for having a POSITIVE IMPACT on cardiovascular results (outcomes) beyond (unrelated to) weight loss.

More to come and most probably from the American College of Cardiology meeting in San Diego this month. Regardless, having strength in weight loss AND HEART disease is a true breakthrough in medicines.

New essential Guide to Prescription Drugs, Update on Alcohol communicates author concerns

The new Essential Guide to Prescription Drugs, Update on Alcohol will help bring detailed information ot patients and families about crucial alcohol drug interactions, impact of binge and risky drinking and much more.

Current national coverage is expanding. www.fox19.com/story/28217302/6-people-die-each-day-from

News on The essential Guide to Prescription Drugs, Update on alcohol now available

 

dr rybacki in white coat Ongoing news pick up of the release of the Essential Guide to Prescription Drugs, Update on alcohol (now available on Amazon) continues to spread.

Members Only: 

dr rybacki in white coat Ongoing news pick up of the release of the Essential Guide to Prescription Drugs, Update on alcohol (now available on Amazon) continues to spread.

Essential Guide eBook seeks to prevent interactions  - KEYC - Mankato News, Weather, Sports - http://www.keyc.com/story/28217302/6-people-die-each-day-from-alcohol-poisoning-new-essential-guide-to-prescription-drugs-ebook-seeks-to-prevent-interactions-and-deaths#.VPFFRnzoZPs.twitter

FDA announces easier road and forms for experimental (investigational) medicines

 

The FDA IS listening

Members Only: 

The FDA IS listening

last resort Dr. Peter Lurie from the FDA announced a large step to help people looking to investigational medicines to treat serious diseases and conditions. The FDA listened well to the vulnerable patients and to physicians trying to navigate what was a complicated course to treatment.

The new draft document is called the Individual Patient expanded Access Applications: Form FDA 3926. This is complicated in the name alone. When the process is finalized, the form will immensely simplify and accelerate the process that your doctor will have to use to get an experimental (in FDA lingo-investigational) drug or biological treatment while it is still being tested to establish safety and efficacy. As usual, I will detail the true breakthroughs in medicines and those with particular interest in The Essential Guide to Prescription Drugs.

The form is still detailed, but FDA estimates hold that a doctor will need 45 minutes versus 100 HOURS to fill in the information. Nice move from the FDA at a time when physicians and patient just want a better way to attack disease. blogs.fda.gov/fdavoice/index.php/2015/02/a-big-step-to-help-the-patients-most-in-need/

Is the FDA keeping medical devices safe?

 

Is the FDA keeping medical devices safe?

Members Only: 

Is the FDA keeping medical devices safe?

A new program appears to be aimed at further accomplishing exactly that. The name is MDSAP (Medical Device Single Audit Program) It could be a milestone in that people who make medical equipment and  want to sell their products in Australia, Brazil, Canada, the US and Japan. The concept seeks to have a single audit or inspection to ensure that the medical device regulatory requirements are met.

Reviews (audits) will be conducted by third party vendors and medical device regulators in the countries will be able to use these inspection reports to make their regulatory decisions. It looks like the program would standardize the information the regulators get and will reduce the need to perform routine inspections. The people who make the medical equipment may benefit by cutting down on the number of regulatory audits they have to host, letting them keep their plants active making the products they want to sell.

Time will tell if this new MDSAP will be a win win for everyone, but it appears to be just the ticket for a more standard review and fewer inspections, yet better products.  

New flu test may help your doctor decide if it's the flu in 15 mnutes

 

older woman Flu season this year has seen a lot of controversy erupt over what the flu vaccine covers, if it actually causes the flu and many wonder if it still helps your immune system even if it doesn't prevent the flu.

Members Only: 

 

older woman Flu season this year has seen a lot of controversy erupt over what the flu vaccine covers, if it actually causes the flu and many wonder if it still helps your immune system even if it doesn't prevent the flu.

Yes, it covers about 23% (effectiveness) of the flu (viruses that are around). No, it doesn’t cause the flu. Yes, you can still get the shot or the spray and it will challenge your immune system (boost immunity) and it will lessen the severity of the flu symptoms if you get the flu. Benefits in immunity may work in strange ways in some years and the “guess” (based on science) of the 3 or 4 viruses that will cause the flu in a given flu season isn’t always correct. Bottom line is that getting a spray or shot with even the wrong virus still boosts your immune system and offers some coverage.

As in past years, if you or a family member do get the flu, it is important to go to the doctor quickly if you plan to try to get Tamiflu. Oseltamivir (Tamiflu) is best started immediately on flu symptoms. The longer you delay, the less the benefit will be and it must be started within 48 hours. There are great symptom checkers on the CDC web site to help you tell the difference between some breathing (respiratory) infections and the flu (visit them at www.CDC.gov). Your doctor may face the treat or not to treat dilemma. This is important if you have diabetes or a heart condition or cancer as the flu can be devastating. The interesting new development is an easier/more prevalent potential use of a lab test to diagnose the flu.

Enter Alere i. Yes, Alere i. The company received a CLIA waver (Clinical Laboratory Improvement Ammendments) for their test. What this means is that the test and technology is simple enough to be used by personnel in a doctor’s office or free-standing Emergency Department. Their test is very fast (about 15 minutes) and uses the latest desirable technology (nucleic acid based) approach. This is the first CLIA waiver for such a flu (influenza A or B) test and means that you and your family could have the convenience of an accurate quick test in a non-traditional laboratory site. This will also help your doctor make treatment decisions sooner and help you get a handle on the flu or appropriate treatment if it isn’t the flu.   

Technology plus medicines, improved population health and targeted treatments for 2015. I will make mention of this test in the upcoming Essential Guide to Prescription Drugs!

 

Radon and cancer impact in your home?

 

black haired woman Could the dangers of radon be lurking in your home? There is a great article on this which does not relate to presctiption medicines, but is a real population health risk.

Members Only: 

 

black haired woman Could the dangers of radon be lurking in your home? There is a great article on this which does not relate to presctiption medicines, but is a real population health risk.

I was surprised at Radon and lack of testing and impact on population health. Time for me to get a radon test kit http://go.usa.gov/MKTW

This website is not intended as medical advice, and you should consult your doctor before changing or adding any medicines or vitamins to those you may now be taking and about applying any strategies BEFORE you adopt any approach in this report. While diligent care has been taken to ensure the accuracy of the information provided during the preparation of this edition, no claim is made that all known actions, uses or side effects, strategies for cost containment, targets or cholesterol pathways are included in this report. The accuracy and currentness of information are ever subject to change relative to new guidelines, new information derived from drug research, development and general usage.